The S836S/3’UTR RET haplotype (GTCAC) was associated with higher rates of metastatic disease as compared to patients without GTCAC haplotype (87.5 vs 53.9%, P = 0.013 and 60 vs 16.8%, P = 0.001) (Table 4). Here, RET is linked to metastatic neoplasm.